Cetirizine Dosing Considerations

Special Populations

• The British Journal of Dermatology recommends considering dose reduction in elderly patients (≥65 years) due to potential decreased renal function with age 1, 2
• For patients with moderate renal impairment (creatinine clearance 10-30 mL/min), the British Journal of Dermatology suggests reducing the dose by half 1, 2
• In cases of severe renal impairment (creatinine clearance <10 mL/min), the British Journal of Dermatology advises avoiding cetirizine 1, 2
• The British Journal of Dermatology recommends using cetirizine with caution in patients with hepatic impairment, though specific dose adjustments are not well-established 1

Administration Considerations

• The British Journal of Dermatology notes that cetirizine can be taken with or without food, but taking with meals may improve gastrointestinal tolerability 3
• Evening dosing of cetirizine may help minimize sedative effects, particularly since cetirizine can be more sedating than other second-generation antihistamines 2, 4

Common Pitfalls to Avoid

• The British Journal of Dermatology warns against exceeding recommended daily doses of cetirizine, as it can cause sedation, especially at higher doses 2
• The British Journal of Dermatology recommends discontinuing cetirizine 6 days before allergy skin testing due to its shorter half-life 1
• The British Journal of Dermatology advises avoiding cetirizine in pregnancy, especially the first trimester, although it is FDA Pregnancy Category B with no evidence of fetal harm 2
• The British Journal of Dermatology cautions against combining cetirizine with other sedating antihistamines without medical supervision due to additive CNS effects 2

If Inadequate Response

• The British Journal of Dermatology suggests considering switching to alternative second-generation antihistamines rather than increasing cetirizine frequency 5
• Adding montelukast 10 mg to cetirizine 5 mg once daily provides equal efficacy to cetirizine 10 mg with less sedation, according to the British Journal of Dermatology 5
• Increasing doses above licensed recommendations is common practice when benefits outweigh risks, though this should be done cautiously, as noted by the British Journal of Dermatology 1, 2